Up to 40% of patients with medulloblastoma receive a diagnosis of #posteriorfossasyndrome , yet simple & preventative measures could reduce the incidence by 75%. Today, I presented findings from the St. Jude Research clinical trial #SJMB12 on the experience with PFS. posteriorfossasociety

Symbolizing hope through change, live butterflies were released on campus yesterday to mark our commitment to advancing cures for pediatric #EpENDymomas . With the guidance of CERN Foundation, the event also featured talks from Stephen C. Mack, Dr. Bertrand & inspiring patient families

Thank you to all who tuned into my Q&A & book signing today St. Jude Research Global #NeuroOnc Training Seminar. It is a pleasure to meet physicians from across the globe, dedicated in improving outcomes for pediatric #BrainTumors

I will be hosting both a Q&A and a signing of my book “Brain Tumors in Children” at the St. Jude Global Academy: #NeuroOnc Training Seminar, a three-day @stjuderesearch seminar that seeks to train clinicians worldwide in treating children with #braintumors .

Proud to be introducing my mentee Giles Robinson at his faculty promotion seminar today. In his work, Giles has greatly impacted the landscape of pediatric #braintumor research & care. Today marks a significant step in his career path.

The 2024 posteriorfossasociety global meeting provides a necessary step towards greater alignment on the characterization of #posteriorfossasyndrome amongst #braintumor providers, which would help further #PFS research and clinical care. Register today: stjude.org/pbii-symposium

Tomorrow, at 11am, I will be presenting my faculty promotion seminar titled 'Revolutionizing Pediatric CNS Tumor Treatment Through an Improved Understanding of Disease' at St. Jude Research. Thrilled to have Amar Gajjar introduce me to the stage. #NeuroOnc

Our front-line infant medulloblastoma trial is now open to enrollment in Children's Minnesota childrensmn.org/2024/02/16/two…

Infants diagnosed with medulloblastoma are eligible for #SJiMB21 – a multi-center phase 2 clinical trial that aims to reduce long-term effects and increase survival using risk-based therapy. Find out how to enroll: stjude.org/sjimb21

Sending love to our patients and families this Valentine’s Day.

#SJ901 , a @stjuderesearch study using a Mirdametnib to treat children & AYAs with low-grade glioma, is enrolling patients in one of 3 treatment cohorts based   on tumor status & history of MEK inhibitor exposure. Learn more: stjude.org/sj901 #PLGG Giles Robinson

Congratulations Dr. Sara Federico on being named the director of the Solid Tumor Division. Members of the dept. of Oncology work together to identify, test and improve treatment for children with cancer. #ChildhoodCancer stjude.org/media-resource…

#Ependymoma research has vastly evolved over the last years with ten different molecular subgroups now described, but progress is still needed to develop new therapeutic strategies and targets. Read the review: tinyurl.com/3xtuezja Paul Klimo Jr. MD MPH

What a day ! Had the opportunity of meeting and hosting doyen of neuro onco Amar Gajjar with masters of neurosurgery #DrDeopujari and #Drmazumdar lots of discussion on how India is improving in #healthcare and need to establish good comprehensive #neuroonco care

Up to 34% of #medulloblastoma patients may develop posterior fossa syndrome (PFS) following brain tumor resection. Join us at the annual @PosteriorFossa conference to learn more about the syndrome: tinyurl.com/bdde25rs

Posterior fossa syndrome (PFS) develops in over 40% of kids with medulloblastoma. The Rotterdam Model, a scoring system said to predict incidences of PFS, was tested on eligible #SJMB12 patients post-op. Read the new Journal of Neurosurgery paper: tinyurl.com/4nm7bekb Paul Klimo Jr. MD MPH

High-dose methotrexate is often used to treat infants with brain tumors. St. Jude researchers conducted a first-of-its-kind study to evaluate the disposition of methotrexate & its primary metabolite 7OHMTX in these infants. Learn more: tinyurl.com/yjcze8uk Clinton Stewart

The Neuro-Oncology & Diagnostic Imaging teams at St. Jude are working with @PosteriorFossa to host the 2nd annual Global Meeting at St. Jude Research. Click here to submit an abstract or to register at an early bird fee: stjude.org/pbii-symposium

Central nervous system tumors are common in adolescents and young adults (AYAs). A Journal of Clinical Oncology review by Dr. Jing Wu, Dr. Elyse Heidelberg, and Amar Gajjar discussed diagnostic approaches and management strategies for tumors that commonly occur in AYAs: go.cancer.gov/UK8upEK